Imogene Haynes-Bleau v. HHS - Pneumococcal, interstitial lung disease, pulmonary fibrosis (2019)

Imogene Haynes-Bleau, an adult, received a pneumococcal conjugate (Prevnar) vaccine on January 14, 2015. Her petition alleged that this vaccine caused a flare of her rheumatoid arthritis, interstitial lung disease, and/or pulmonary fibrosis, and that her subsequent death was a sequela of these vaccine-induced injuries.

The petitioner also alleged that Ms. Haynes-Bleau experienced residual effects of her injury for more than six months.

The parties filed a stipulation for award, agreeing to a lump sum payment of $200,000.00. Respondent denied that the vaccine caused Ms.

Haynes-Bleau's alleged injuries. The Special Master found the stipulation reasonable and adopted it as the decision of the Court, awarding compensation for all damages available under the program.

Frederick Haynes, as Executor of the Estate of Imogene Haynes-Bleau, was substituted as petitioner upon Ms. Haynes-Bleau's death.